Texas

The Drug Utilization Review Board posted the agenda for October 21 meeting. Refer to the Texas Drug Utilization Review Board Handbook for the instructions about submitting written materials to the board before the meeting and public testifying on the day of the meeting.

Also in Texas, the Health and Human Services Commission (HHSC) updated the July 2022 Medicaid Preferred Drug List on September 28 and provided the following updates:

• September 2022 Specialty Drug List Available
• Temporary Change in PDL Status for Clonidine Transdermal Patches Effective Sept. 26
• Clinical Prior Authorization Criteria Revisions Implement for Medicaid Fee-for-Service On Oct. 26

For more information, contact NACDS’ Mary Staples at 817-442-1155.